Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients
Open Access
- 13 May 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neuroinflammation
- Vol. 8 (1), 47
- https://doi.org/10.1186/1742-2094-8-47
Abstract
Background Vascular endothelial growth factor-A (VEGF-A) and chemokne ligand-2 (CCL2) levels have been examined in Amyotrophic Lateral Sclerosis (ALS) patients in Western countries. We measured these values in North Indian ALS patients, since these patients display considerably enhanced survival duration. Methods Sporadic ALS patients were included on the basis of El Escorial criteria. VEGF-A and CCL2 levels were analyzed in serum and cerebrospinal fluid (CSF) of 50 ALS patients using enzyme linked immunosorbent assay (ELISA) and compared with normal controls. Their levels were adjusted for possible confounders like cigarette smoking, alcohol and meat consumption. Results Contrary to previous studies, VEGF-A was found to be elevated significantly in serum and CSF in ALS patient population studied. We also found an increase in CCL2 levels in CSF of these ALS patients. Serum and CSF from definite ALS revealed higher VEGF-A as compared to probable and possible ALS. CCL2 was unaltered between definite, probable and possible ALS. Univariate and multivariate analysis revealed a lack of association of smoking, alcohol and meat consumption with VEGF-A and CCL2 levels. Conclusions VEGF-A upregulation may indicate an activation of compensatory responses in ALS which may reflect or in fact account for increased survival of North Indian ALS patients after disease onset. The intrathecal synthesis of CCL2 suggests the involvement of adult neural stem cells and microglial activation in ALS pathogenesis which needs further investigation.This publication has 25 references indexed in Scilit:
- Occurrence of PARK2 Mutations in a Never-Smoker Population with Parkinson’s Disease in North IndiaNeuroepidemiology, 2010
- Commentary on Professor Stephen Hawking's disability adviceAnnals of Neurosciences, 2009
- Role of monocyte chemoattractant protein‐1 (MCP‐1/CCL2) in migration of neural progenitor cells toward glial tumorsJournal of Neuroscience Research, 2009
- Modulation of vascular endothelial growth factor (VEGF) expression in motor neurons and its electrophysiological effectsBrain Research Bulletin, 2008
- Chemokine ligand 2 (CCL2) induces migration and differentiation of subventricular zone cells after strokeJournal of Neuroscience Research, 2007
- Cord Blood Mesenchymal Stem Cells: Potential Use in Neurological DisordersStem Cells and Development, 2006
- Biphasic effects of exogenous VEGF on VEGF expression of adult neural progenitorsNeuroscience Letters, 2006
- Monocyte chemoattractant protein-1–induced angiogenesis is mediated by vascular endothelial growth factor-ABlood, 2005
- VEGF is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosisNeuroReport, 2002
- THE PROGNOSIS OF MOTOR NEURON DISEASE IN NIGERIAN AFRICANSBrain, 1974